Scholar Rock Holding (SRRK) Current Deferred Revenue (2017 - 2021)

Scholar Rock Holding's (SRRK) quarterly Current Deferred Revenue came in at $33.2 million in Q4 2021, up 76.41% year-on-year from $18.8 million in Q4 2020, and down 10.87% quarter-over-quarter from $37.2 million in Q3 2021.

Scholar Rock Holding (SRRK) Current Deferred Revenue (2017 - 2021) Analysis & Trends

Scholar Rock Holding's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $33.2 million for Q4 2021.

  • On a quarterly basis, Current Deferred Revenue rose 76.41% year-over-year to $33.2 million in Q4 2021; TTM through Dec 2021 was $33.2 million, a 76.41% increase from a year earlier, with the FY2021 full-year figure at $33.2 million, up 76.41% from the prior year.
  • Current Deferred Revenue retreated to $33.2 million in Q4 2021 per SRRK's latest filing, from $37.2 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $47.3 million in Q1 2021 and bottomed at $228000.0 in Q4 2017.
  • The 5-year median for Current Deferred Revenue is $20.6 million (2019), against an average of $24.5 million.
  • Across the five-year window, Current Deferred Revenue jumped 8763.6% in 2018 and slumped 35.84% in 2020, its largest moves.
  • Year by year, Current Deferred Revenue stood at $228000.0 in 2017, then soared by 8763.6% to $20.2 million in 2018, then advanced by 3.53% to $20.9 million in 2019, then declined by 10.07% to $18.8 million in 2020, then soared by 76.41% to $33.2 million in 2021.
  • Per Business Quant, the three latest SRRK Current Deferred Revenue figures stand at $33.2 million (Q4 2021), $37.2 million (Q3 2021), and $42.7 million (Q2 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Scholar Rock Holding 6.30 Bn 6.30 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 33.19 Mn
Sep 30, 2021 37.24 Mn
Jun 30, 2021 42.71 Mn
Mar 31, 2021 47.30 Mn
Dec 31, 2020 18.82 Mn
Sep 30, 2020 16.71 Mn
Jun 30, 2020 20.36 Mn
Mar 31, 2020 16.27 Mn
Dec 31, 2019 20.92 Mn
Sep 30, 2019 20.25 Mn
Jun 30, 2019 23.52 Mn
Mar 31, 2019 25.36 Mn
Dec 31, 2018 20.21 Mn
Dec 31, 2017 228,000.00